SEC Form 4 · accession 0001179110-17-010334

SUNESIS PHARMACEUTICALS INC · SNSS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President and CEO · Director

Period of report

Jul 10, 2017

Accepted (ET)

Jul 12, 2017 · 5:32 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001061027

Table I — non-derivative securities

No Table I lines on this filing.

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F2,F1	$93.24	Jul 10, 2017	D	4,306	D	—	Sep 13, 2017	Common Stock	4,306	0	D
Employee Stock Option (right to buy)^F2,F1	$17.64	Jul 10, 2017	D	18,333	D	—	Aug 31, 2019	Common Stock	18,333	0	D
Employee Stock Option (right to buy)^F2,F1	$12.54	Jul 10, 2017	D	118,435	D	—	Jun 30, 2021	Common Stock	118,435	0	D
Employee Stock Option (right to buy)^F2,F1	$10.44	Jul 10, 2017	D	70,834	D	—	Feb 28, 2022	Common Stock	70,834	0	D
Employee Stock Option (right to buy)^F2,F1	$31.32	Jul 10, 2017	D	50,000	D	—	Feb 28, 2023	Common Stock	50,000	0	D
Employee Stock Option (right to buy)^F2,F1	$39.30	Jul 10, 2017	D	50,001	D	—	Feb 28, 2024	Common Stock	50,001	0	D
Employee Stock Option (right to buy)^F2,F1	$10.20	Jul 10, 2017	D	50,000	D	—	Oct 31, 2024	Common Stock	50,000	0	D
Employee Stock Option (right to buy)^F2,F3	$2.62	Jul 10, 2017	A	17,582	A	—	Jul 10, 2027	Common Stock	17,582	17,582	D
Employee Stock Option(right to buy)^F2,F4	$2.62	Jul 10, 2017	A	240,177	A	—	Jul 10, 2027	Common Stock	240,177	240,177	D

F1The option grant provided for vesting in monthly installments over four (4) years measured from the option grant date, provided that at each such vesting date, the reporting person shall then be providing service (as defined in the Option Plan) to the Company.
F2On July 10, 2017, the issuer canceled, pursuant to the issuer's option exchange program, the following options: (1) an option granted on 9/13/07 for 4,306 shares; an option granted on 8/31/09 for 18,333 shares; an option granted on 6/30/11 for 118,435 shares; an option granted on 2/29/12 for 70,834; an option granted on 2/28/13 for 50,000 shares; an option granted on 2/28/14 for 50,001 shares and option granted on 10/31/14 for 50,000 shares. In exchange, the reporting person received two replacement options, one for an aggregate of 17,582 shares, and another replacement option for an aggregate of 240,177 shares, each having an exercise price of $2.62 a share.
F3The option vests in monthly installments over three (3) years measured from the option grant date, provided that at each such vesting date, the reporting person shall then be providing service (as defined in the Option Plan) to the Company.
F4The option vests in monthly installments over two (2) years measured from the option grant date, provided that at each such vesting date, the reporting person shall then be providing service (as defined in the Option Plan) to the Company.